Navigation Links
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
Date:9/24/2008

ANNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting two posters and an oral presentation on its medical countermeasures programs, Protexia(R) (rBChE) and Valortim(R) at the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2008 / BARDA Industry Day being held in Alexandria, VA, September 24 - 26, 2008.

David P. Wright, President and Chief Executive Officer of PharmAthene commented, "We want to commend BARDA's new leadership for moving forward aggressively to engage with industry as a partner, and for their commitment to providing greater transparency and a long-term strategy for biodefense medical countermeasures research, development and procurement."

"We are delighted to have the opportunity to present these data at the PHEMCE conference, which is an important industry meeting for companies in the biodefense sector. As the data illustrate, PharmAthene continues to advance its pipeline and further its leadership position in biodefense by working collaboratively with the U.S. government to develop unique animal models that can potentially accelerate product commercialization," Mr. Wright continued.

Protexia(R), a recombinant version of human butyrylcholinesterase (BChE), is being developed as a pre- and post-exposure therapy for casualties on the battlefield or civilian victims of nerve agent attacks. Valortim(R), in co-development with Medarex, Inc., (Nasdaq:

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)...  EP Global Communications, Inc. (Public OTC: EPGL) announced today ... Company about discussing EPGL,s electronic contact lens technologies.  ... 3, 2015.  Novartis CEO Joe Jimenez ... electronic contact lens market could be worth tens ... years.  Novartis partnered with Google in 2014 to ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... Medical Technologies announced today the release of its ... view used to navigate multiple planes simultaneously. This ... pulmonology, enabling physicians to view the location of ... view without any radiation being delivered to the ...
... BOCA RATON, Fla. and FARGO, N.D., Dec. 16, 2011  Crystal3 ... in Boca Raton, FL, announced today that it has ... of Fargo, ND. Financial terms of the transaction were ... change to Global Pharma Analytics. Founded in ...
Cached Medicine Technology:Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View 2Crystal3 Labs Acquired by Individual Investor, Vithalbhai Dhaduk, M.D. 2
(Date:8/1/2015)... , ... August 01, 2015 , ... The condition where ... both men and women often causing pain and discomfort. Those who spend a lot ... problem, and Northeast Houston Vein Center is doing what it can to create awareness ...
(Date:8/1/2015)... ... August 01, 2015 , ... Professional ... portfolio company has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 ... state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... allows users to clarify, edit and delete any message including ones already sent. , ...
(Date:7/31/2015)... ... 31, 2015 , ... When the weather turned hot and warm-season turfgrasses, such ... sod called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) for short. Incidentally, both ... this new type of sod, Super-Sod is giving away red Adirondack chairs with the ...
(Date:7/31/2015)... ... ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and black diamond ... non-surgical fat reduction in New York. Due to its unparalleled level of experience ... Many patients travel to New York to get their non-surgical skin tightening and body ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
... to Go Pink in October, HARRISBURG, Pa., Sept. ... pink as the Pennsylvania,Commission for Women kicks-off Breast Cancer ... have so valiantly fought the disease., The commission ... as,a tool to educate the public on the disease., ...
... Inc., a,global supplier of private-label infant formulas, announced ... more retailers are looking to offer,formulas manufactured in ... of mothers and fathers in Canada understand that ... there is a savings,up to 50 percent, PBM ...
... interventional techniques and devices will be released at ... global annual scientific symposium of the Cardiovascular Research ... data that promises to advance the field of ... safety and efficacy of new devices, including drug-eluting ...
... Offset by Charge for Goodwill Impairment, SALT LAKE ... today announced results for its fourth quarter,and fiscal 2008 ... acquisitions concluded in the fourth,quarter of fiscal year 2007 ... recorded significant revenue increases for the fourth quarter and,full ...
... SAN FRANCISCO, Sept. 29 Since the death of ... Hospital in Bangkok, Thailand,James Goldberg has attempted to see ... the story to its roots, I was astounded to ... of the American public,due in part to rubber stamp ...
... up 12.2 ... costs, CHICAGO, Sept. 29 Hospital-acquired,infections, hospital-acquired ... for one out of every six claims, according ... Benchmark,Analysis, released today by leading risk management services ...
Cached Medicine News:Health News:PA Commission for Women Kicks Off Breast Cancer Awareness Month With Pink Fountain Tour 2Health News:Canadian Brand-Name Infant Formulas No Better than Private-Label Formulas 2Health News:TCT update: press conference schedule announced for TCT 2Health News:TCT update: press conference schedule announced for TCT 3Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 2Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 3Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 4Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 5Health News:New Trend of Healthcare Companies Sending Patients Abroad for Surgery is Dangerous Says James Goldberg Whose Son Died Following Surgery in Thailand 2Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 2Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 3Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 4Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 5